Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics

被引:4
|
作者
Sterns, Laurence D. [1 ,6 ]
Auricchio, Angelo [2 ]
Schloss, Edward J. [3 ]
Lexcen, Dan [4 ]
Jacobsen, Luke [4 ]
DeGroot, Paul [4 ]
Molan, Amy [4 ]
Kurita, Takashi [5 ]
机构
[1] Vancouver Isl Arrhythmia Clin, Victoria, BC, Canada
[2] Ist Cardioctr Ticino, Div Cardiol, Lugano, Switzerland
[3] Christ Hosp, Cincinnati, OH USA
[4] Medtronic Inc, Mounds View, MN USA
[5] Kindai Univ, Sch Med, Dept Med, Div Cardiol, Osaka, Japan
[6] 300-3680 Uptown Blvd, Victoria, BC V8Z 0B9, Canada
关键词
Antitachycardia pacing; Implantable cardioverter-defi-brillator; Cardiac resynchronization therapy; defibrillator; Shock reduction; Device programming; FAST VENTRICULAR-TACHYCARDIA; LONG-DETECTION INTERVAL; QUALITY-OF-LIFE; PREVENTION PATIENTS; UNNECESSARY SHOCKS; MULTIPLE BURSTS; INAPPROPRIATE; REDUCTION; THERAPIES; EFFICACY;
D O I
10.1016/j.hrthm.2022.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Antitachycardia pacing (ATP) is an established implantable cardioverter-defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD shocks. However, factors influencing ATP success are not well understood.OBJECTIVE The purpose of this study was to examine ATP success rates by patient, device, and programming characteristics.METHODS This retrospective analysis of the PainFree SmartShock Technology study included spontaneous ATP-treated monomorphic VT episodes. ATP success rates were calculated for various factors. Also, the relationship of ATP programming on shock burden and syncope were investigated.RESULTS Of the 2770 enrolled patients (2200 [79%] male; mean age 65 years), 1699 (61%) received an ICD and 1071 (39%) a car-diac resynchronization therapy - defibrillator. ATP had .80% rate of success for terminating VTs overall, with similar rates observed between ICD and cardiac resynchronization therapy - defibrillator devices (82.2% vs 80.3%, respectively; P = .81) as well as between primary and secondary prevention patients with ICDs (77.2% vs 83.9% respectively; P = .25). Arrhythmias with a median cycle length of >320 ms had a significantly higher ATP success rate (88.0%; 95% confidence interval 84.8%-90.6%). The cumulative percentage of ATP success increased from 71% at 1 ATP sequence delivered to 87% at >8 sequences delivered. Programming more ATP sequences was associated with lower shock burden (P = .0005). There was no evidence that more sequences were associated with higher rates of syncope (P = .16).CONCLUSION Delivering more ATP sequences resulted in a higher overall success of terminating VTs, while programming more ATP was associated with decreased shock burden and no evidence of increased syncope or acceleration. This suggests that more ATP se-quences should be programmed when possible, but confirmation in prospective studies will be necessary.
引用
收藏
页码:190 / 197
页数:8
相关论文
共 50 条
  • [41] Implantable cardioverter-defibrillators and complications
    Sinclair, CT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07): : 734 - 734
  • [42] Automatic implantable cardioverter-defibrillators
    Smith, WM
    Ideker, RE
    [J]. ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, 1999, 1 : 331 - 346
  • [43] Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: The importance of the patient's sex
    Peters, RW
    Zhang, XZ
    Gold, MR
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (01): : 70 - 74
  • [44] Deactivation of implantable cardioverter-defibrillators: results of patient surveys
    Herman, Dalibor
    Stros, Petr
    Curila, Karol
    Kebza, Vladimir
    Osmancik, Pavel
    [J]. EUROPACE, 2013, 15 (07): : 963 - 969
  • [45] Efficacy and safety of programming a high number of antitachycardia pacing sequences for fast ventricular tachycardia in implantable cardioverter-defibrillators recipients: a single center pilot study
    Martins, R. P.
    Blangy, H.
    Muresan, L.
    Freysz, L.
    Groben, L.
    Zinzius, P. Y.
    Schwartz, J.
    Sellal, J. M.
    Aliot, E.
    Sadoul, N.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 311 - 311
  • [46] Implantable cardioverter-defibrillators and driving
    Chen, Peng-Sheng
    [J]. HEART RHYTHM, 2007, 4 (05) : 688 - 689
  • [47] Programming implantable cardioverter-defibrillators in primary prevention: Higher or later
    Clementy, Nicolas
    Pierre, Bertrand
    Simeon, Edouard
    Lallemand, Benedicte
    Fauchier, Laurent
    Babuty, Dominique
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (05) : 308 - 318
  • [48] Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability
    Swerdlow, CD
    Peter, CT
    Kass, RM
    Gang, ES
    Mandel, WJ
    Hwang, C
    Martin, DJ
    Chen, PS
    [J]. CIRCULATION, 1997, 95 (06) : 1497 - 1504
  • [49] A comparison of the output characteristics of several implantable cardioverter-defibrillators
    Thammanomai, Apiradee
    Sweeney, Michael O.
    Eisenberg, Solomon R.
    [J]. HEART RHYTHM, 2006, 3 (09) : 1053 - 1059
  • [50] Heart failure devices - Implantable cardioverter-defibrillators and biventricular pacing therapy
    Kadish, A
    Mehra, M
    [J]. CIRCULATION, 2005, 111 (24) : 3327 - 3335